XBiotech Current Ratio from 2010 to 2025
| XBIT Stock | USD 2.35 0.05 2.08% |
Current Ratio | First Reported 2010-12-31 | Previous Quarter 11.55690169 | Current Value 20.47 | Quarterly Volatility 24.82351613 |
Check XBiotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among XBiotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Interest Expense of 766.6 K or Selling General Administrative of 7.7 M, as well as many indicators such as Price To Sales Ratio of 14.88, Dividend Yield of 0.18 or PTB Ratio of 0.63. XBiotech financial statements analysis is a perfect complement when working with XBiotech Valuation or Volatility modules.
XBiotech | Current Ratio | Build AI portfolio with XBiotech Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for XBiotech Stock Analysis
When running XBiotech's price analysis, check to measure XBiotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XBiotech is operating at the current time. Most of XBiotech's value examination focuses on studying past and present price action to predict the probability of XBiotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XBiotech's price. Additionally, you may evaluate how the addition of XBiotech to your portfolios can decrease your overall portfolio volatility.